Drug Shortage Report for AURO-ALENDRONATE
Report ID | 96271 |
Drug Identification Number | 02388553 |
Brand name | AURO-ALENDRONATE |
Common or Proper name | Alendronic Acid |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | ALENDRONIC ACID |
Strength(s) | 70MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 1x4 |
ATC code | M05BA |
ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2019-10-09 |
Estimated end date | |
Actual end date | 2020-03-30 |
Shortage status | Resolved |
Updated date | 2020-03-31 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2020-03-31 | French | Compare |
v9 | 2020-03-31 | English | Compare |
v8 | 2020-03-13 | French | Compare |
v7 | 2020-03-13 | English | Compare |
v6 | 2019-11-11 | French | Compare |
v5 | 2019-11-11 | English | Compare |
v4 | 2019-10-24 | French | Compare |
v3 | 2019-10-24 | English | Compare |
v2 | 2019-10-11 | French | Compare |
v1 | 2019-10-11 | English | Compare |
Showing 1 to 10 of 10